Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.
Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.
Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
Download a Brochure Join Our Mailing List